Biocon Biologics receives EU GMP Certification for multiple Biosimilars manufacturing facilities in… EP News Bureau May 19, 2020 These facilities are used for the manufacture of DS and DP for Biosimilars: Bevacizumab, Trastuzumab, Pegfilgrastim and secondary…
